We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Nanoflares Detect Live Tumor Cells in Human Blood

By LabMedica International staff writers
Posted on 07 Dec 2014
Print article
Image: NanoFlares-specially designed stem cells that have been developed to detect blood-borne cancers. When the cells come in contact with cancerous cells, they emit light (Photo courtesy of the International Institute for Nanotechnology at Northwestern University).
Image: NanoFlares-specially designed stem cells that have been developed to detect blood-borne cancers. When the cells come in contact with cancerous cells, they emit light (Photo courtesy of the International Institute for Nanotechnology at Northwestern University).
Metastasis portends a poor prognosis for cancer patients and primary tumor cells disseminate through the bloodstream before the appearance of detectable metastatic lesions.

The analysis of cancer cells in blood, the so-called circulating tumor cells (CTCs), may provide unprecedented opportunities for metastatic risk assessment and investigations using NanoFlares, when coupled with flow cytometry, can be used to fluorescently detect genetic markers of CTCs in the context of whole blood.

Scientists at Northwestern University (Evanston, IL, USA) working with colleagues from various institutions, used NanoFlare technology designed to recognize a specific genetic code snippet associated with a cancer. The core nanoparticle, only 13 nanometers in diameter, enters cells, and the NanoFlare seeks its target. The genetic targets were messenger RNA (mRNA) that code for certain proteins known to be biomarkers for aggressive breast cancer cells.

The team first used the blood of healthy individuals, spiking some of the blood with living breast cancer cells to see if the NanoFlares could detect them and they used unspiked blood as a control. They tested four different NanoFlares, each with a different genetic target relevant to breast cancer metastasis. Samples were analyzed by flow cytometry using the LSRFortessa Analyzer (BD Biosciences; San Jose, CA, USA). The technology successfully detected the cancer cells with less than 1% incidence of false-negative results.

Chad A. Mirkin, PhD, the director of the Institute of Nanotechnology and senior author of the study said, “This technology has the potential to profoundly change the way breast cancer in particular and cancers in general are both studied and treated. Cancers are very genetically diverse, and it's important to know what cancer subtype a patient has. Now you can think about collecting a patient's cells and studying how those cells respond to different therapies. The way a patient responds to treatment depends on the genetic makeup of the cancer.” The study was published on November 17, 2014, in the journal Proceedings of the National Academy of Sciences of the United States of America (PNAS).

Related Links:

Northwestern University
BD Biosciences 


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.